<

ABSCIENCES (EPA:AB) AB Science announces positive top-line Phase 2B/3 results for oral masitinib in progressive forms of multiple sclerosis

Transparency directive : regulatory news

20/02/2020 19:39



Other stories

25/04/2024 10:08
25/04/2024 10:13
25/04/2024 11:03
25/04/2024 11:39
25/04/2024 08:27
25/04/2024 10:41
25/04/2024 03:30
25/04/2024 06:30
25/04/2024 09:06
25/04/2024 02:15
25/04/2024 10:53
25/04/2024 11:44
25/04/2024 07:00
25/04/2024 09:11
25/04/2024 09:35
25/04/2024 08:13
25/04/2024 01:01
25/04/2024 06:05
25/04/2024 08:13
24/04/2024 22:30
24/04/2024 09:06
25/04/2024 02:00
25/04/2024 02:05
25/04/2024 02:34
25/04/2024 07:08
25/04/2024 08:00
25/04/2024 09:36
25/04/2024 08:00
25/04/2024 11:04
25/04/2024 10:17
24/04/2024 08:05
24/04/2024 18:04
24/04/2024 06:28
25/04/2024 07:30
25/04/2024 06:00
24/04/2024 23:40
25/04/2024 07:00
24/04/2024 03:26